Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ultrasound-guided posterior antebrachial cutaneous nerve block sensory mapping
ACTRN12618000891224Phase 4Completed
- Sponsor
- Concord Repatriation General Hospital
- Start
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of lidocaine, sponsored by Concord Repatriation General Hospital. Primary endpoint: Total cutaneous sensory block area. Started Nov 2018; status: completed.
02
Drugs
lidocaine
Beyond the preview
Go deeper on ACTRN12618000891224.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12618000891224.